Ghiringhelli F, Isambert N, Ladoire S. Degarelix as a new antiangiogenic agent for metastatic colon cancer? World J Gastroenterol 2013; 19(5): 769-772 [PMID: 23431078 DOI: 10.3748/wjg.v19.i5.769]
Corresponding Author of This Article
Francois Ghiringhelli, MD, PhD, Departement of Oncologie Medicale, Centre Georges Francois Leclerc, 1 rue du Professeur Marion, 21000 Dijon, France. fghiringhelli@cgfl.fr
Research Domain of This Article
Oncology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/